[September 25, 2017]

Global Tumor Ablation Market Forecast & Regional Analysis 2017-2023 - Research and Markets

The "Global Tumor Ablation Market Forecast & Regional Analysis 2023" report has been added to Research and Markets' offering.

The overall market opportunity for Tumor ablation therapy is expected to surpass US$ 1.2 Billion by 2023.

Tumor ablation is an emerging cancer therapy method that is gaining steady and wide acceptance as a successful cancer therapeutic. Tumor ablation is a method that ensured higher efficacy of tumor cell treatment with minimum toxicity or side effects. This form of treatment involves the destruction of tumors using heat, low temperature and chemical agents that are introduced into the tumor regions using a guided needle through a small hole.

Tumor ablation therapy proves to be an excellent option over other conventional methods of treatment due to its minimum invasiveness. It has been considered to be the best alternative in patients who cannot undergo surgery for medical reasons. It has proven to be highly effective and safe in the treatment of patients having four or few tumors limited to a small region, for larger and greater number of tumors, chemotherapy is considered much more effective.

Key Topics Covered:

1. Tumor Ablation - A Minimally Invasive Cancer Therapeutic

1.1 Prologue to Tumor Ablation Therapy

1.2 History & Progress of Tumor Ablation Therapy

2. Demand & Features of the Tumor Ablation Therapy

2.1 Dire Need for a Safe & Non-Invasive Cancer Therapy

2.2 Compelling Features of the Tumor Ablation Therapy

3. Tumor Ablation - Providing an Edge over Existing Cancer Therapeutics

3.1 Direct Tumoricidal Effect

3.2 Minimal Invasive Therapy

3.3 Affordability

3.4 Applicable to a Non-surgical Candidate

3.5 Swift (News - Alert) Procedure With aster Recovery

3.6 Can be Repeated Multiple Times

4. Technological Aspect (News - Alert) of Tumor Ablation Therapy

5. Radiofrequency Ablation Therapy

5.1 Overview

5.2 Therapeutic Mechanism of Radiofrequency Ablation

6. Microwave Tumor Ablation Therapy

6.1 The Physics of Microwave & its Therapeutic Mechanism

6.2 Superiority of Microwave Ablation Therapy Compared to Radiofrequency Ablation Therapy

7. Cryoablation Therapy

7.1 Cryoablation Therapy - An Emerging Modern Cancer Ablation Procedure

7.2 Procedure, Mechanism & Clinical Applications of Cryoablation Therapy

8. High Intensity Focused Ultrasound (HIFU)

8.1 An Insight into the Progress of HIFU over the Last Decade

8.2 Working Mechanism of High Intensity Focused Ultrasound

9. Other Tumor Ablation Therapeutics

9.1 Laser Induced Thermal Therapy for Tumor Ablation

9.2 Irreversible Electroporation Ablation (IER)

10. Tumor Ablation Types by Mode of Treatment

10.1 Surgical Ablation of Tumors

10.2 Laparoscopic Tumor Ablation

10.3 Percutaneous Tumor Ablation

11. Technology, Devices & Tools Involved in Tumor Ablation Therapy

11.1 Imaging Technologies

11.2 Catheters or Probes

12. Clinical Status of Tumor Ablation Therapy in Various Cancer Types

12.1 Primary Hepatocellular Carcinoma (HCC)

12.2 Non-Small Cell Lung Cancer

12.3 Renal (Kidney Tumor Ablation)

12.4 Prostate Cancer

12.5 Breast Cancer

12.6 Bone Metastasis

12.7 Pancreas

13. Recent Advances in Tumor Ablation Therapy

14. Exploring the Commercial Aspects of Tumor Ablation Therapy

14.1 Cost Benefit Analysis of Tumor Ablation Therapy

14.2 Tumor Ablation Cost Analysis

14.2.1 Common Cost of Tumor Lesion Treatment Using any of the Available Ablation Modalities

14.2.2 Modality Specific Ablation Cost for a 3cm Kidney Lesion

15. Global Tumor Ablation Therapy Market Current Scenario

15.1 Tumor Ablation Market by Technology

15.2 Tumor Ablation Therapy Market by Mode of Treatment

15.3 Tumor Ablation Market by Application

16. Tumor Ablation Therapy Market by Region

17. Global Tumor Ablation Therapy Market Dynamics

17.1 Driving Factors of the Tumor Ablation Market

17.2 Restraining Factors in the Growth of Tumor Ablation Therapy Market

18. Anticipation Regarding the Future of Tumor Ablation Therapy Market

19. Competitive Landscape

19.1 Angiodynamics

19.2 Boston Scientific

19.3 Galil Medicals

19.4 INTIO Inc.

19.5 Medtronic Inc.

19.6 Misonix Inc.

19.7 NeuWave Medical Inc.

19.8 SonaCare Medical

19.9 Medwaves

19.10 BSD Medicals

19.11 ProstaLund

19.12 Halyard Health

For more information about this report visit https://www.researchandmarkets.com/research/8xmxgx/global_tumor

View source version on businesswire.com: http://www.businesswire.com/news/home/20170925005624/en/

[ Back To TMCnet.com's Homepage ]